Metformin and breast cancer risk: a meta-analysis and critical literature review.
about
Metformin and thyroid: an updateMetformin therapy and risk of cancer in patients with type 2 diabetes: systematic reviewThe association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanismsTargeting translation initiation in breast cancerMetformin as an adjuvant treatment for cancer: a systematic review and meta-analysisMedical prevention of breast cancerImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control studyCurrent strategies for the prevention of breast cancerMetformin and breast cancer stage at diagnosis: a population-based studyType 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.Glargine safety, diabetes and cancer.Metformin and breast and gynecological cancer risk among women with diabetes.Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma.Survival of patients with stage IV lung cancer with diabetes treated with metformin.Diabetes, diabetes treatment and breast cancer prognosis.Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant StressTreatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer riskMetformin use and young age lung cancer: A case series reportDiabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.Association between metformin therapy and mortality after breast cancer: a population-based study.Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.Metformin use and endometrial cancer survivalDiabetes, diabetes treatment, and mammographic density in Danish Diet, Cancer, and Health cohort.Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progressionPostmenopausal breast cancer, androgens, and aromatase inhibitors.Diabetes and cancer relationships.Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Clinical studies examining the impact of obesity on breast cancer risk and prognosis.Treatment and outcomes in diabetic breast cancer patients.Sex and gender influences on pharmacological response: an overview.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.The association between metabolic health, obesity phenotype and the risk of breast cancer.Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.Synergistic drug combinations from electronic health records and gene expression.No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA.
P2860
Q26822045-193D1036-4724-4ACF-837F-46FA462B61BCQ26850912-229C60DF-8896-4A20-9D0E-25172772313CQ27026813-E3B00817-23C6-486C-B8CD-96122A5BEABAQ27027284-EAF12193-F762-4E1E-A3B1-6D964C023575Q28074225-C84CBE27-9D2E-4F4F-A0B4-EB4C418AA393Q28086915-A5530ECE-40C5-4B8D-9A12-3B9BC4CEC2BBQ28535372-45DAD297-8091-4585-83D5-3461B3AB8F6FQ33599463-7048C1BB-59BC-4AD5-AAB3-812BCCB1F6D1Q33611185-3AF3992A-D9C6-428D-9ED2-F9A8C7A9E481Q33756414-E0462CFE-5A39-4916-A473-0EBF1EF3253FQ34326924-93EEF019-E7F9-4D30-80B8-8EBD7F9D03A8Q35046074-71C08931-6E6B-4276-B1D8-8A41AAB45E6BQ35115554-4B8B8AC9-872F-43CF-8523-787115192C57Q35153493-C1A17DD4-3F07-424B-BE8F-4B6E45E47C9EQ35373602-4377571E-F959-4CCD-938C-925C30523402Q35782187-2CAF3C7E-23CE-4D3F-9303-29AFA7659472Q35937961-D219BA36-E0BF-4863-AF26-2F00FEB29FF0Q36182935-5B84F1D3-3D3B-451D-9112-FF245277A27FQ36582700-E08A0C86-4410-4436-ADC9-3544EFD3F8A7Q36741232-D0B38DB5-A1B0-42E9-8ACE-BD02B2C27A38Q36794283-38E3E01A-F68B-4A9A-9D87-5A8CCF926E49Q37193432-DCBB6EE1-88D5-4812-9110-A28EABDF9CFAQ37228939-49CB4995-C170-497C-B0E2-E7B6A1CFA538Q37523998-8C1877AD-4B3D-4EAB-93B2-02DFC5A80D12Q37568800-9519887E-5283-4268-AC00-772E64E984F3Q37690552-F07C9F87-F899-4619-A129-EDA5BCC28B7FQ38097730-E386FD8C-D35E-4599-8947-950F6C2913BBQ38097984-6C7F50A8-6848-46E3-A246-F56E47AFBE9DQ38147841-9780DE68-1CE4-4E1E-B207-F120BACB0FD7Q38162118-3AC2CE5A-BC60-4DF2-A84E-A3D594C40EFCQ38180008-9C4794DE-A08B-46E8-9A11-EBAA14AE5D44Q38214338-7160B20A-07E3-49C1-A418-5F536BB84754Q38538492-7C328459-1FB3-4214-987F-78C9327E0F39Q38728567-A855642A-8292-457D-9E1B-986A159154C9Q38924489-80801128-DD3F-44C1-BEA7-A70B95C9A6DEQ38976502-414488C0-126E-4615-B658-747B4F1EBE22Q39111678-6184D684-41AB-4F4B-BFC1-DFAF6508AE85Q40778391-48B2D82F-0121-4E88-8D2D-017105E01F5AQ41241629-B1ED2E6D-DBBD-49E5-8CE2-7EE2FE01E3FEQ42019935-E4112222-FFA9-43A9-9249-1D2332D50D53
P2860
Metformin and breast cancer risk: a meta-analysis and critical literature review.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@ast
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@en
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@nl
type
label
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@ast
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@en
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@nl
prefLabel
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@ast
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@en
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@nl
P2093
P2860
P1476
Metformin and breast cancer risk: a meta-analysis and critical literature review.
@en
P2093
Aaron K Aragaki
Leslie Ochs
Nananda F Col
Rowan T Chlebowski
Vicky Springmann
P2860
P2888
P304
P356
10.1007/S10549-012-2170-X
P407
P577
2012-07-31T00:00:00Z
P5875
P6179
1022720204